• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

马查多-约瑟夫病

Machado-Joseph disease.

作者信息

Sudarsky L, Coutinho P

机构信息

Neurology Service (127), VA Medical Center, West Roxbury, MA 02132, USA.

出版信息

Clin Neurosci. 1995;3(1):17-22.

PMID:7614089
Abstract

Machado-Joseph disease (MJD) is a form of dominantly-inherited ataxia originally described in people of Azorean and Portuguese descent. The disorder has subsequently been identified in Japan, Brazil, Australia, and China. Average age of onset is 35 to 40. Core features include progressive ataxia, dysarthria, postural instability, nystagmus, eyelid retraction, and facial fasciculations. Dystonia is often prominent in younger patients. Three distinct phenotypes appear to reflect the clinical spectrum of a single mutant gene. Neuropathology involves afferent and efferent cerebellar systems, with preservation of cerebellar cortex and inferior olive. Spinocerebellar pathways, substantia nigra, and cranial nerve motor nuclei are involved. The disorder is due to an unstable CAG repeat on chromosome 14q32.1. A dominantly inherited ataxia (SCA-3) in families of French and German descent has also been linked to this segment of chromosome 14. The relationship between MJD and the other dominant inherited ataxias is discussed.

摘要

马查多-约瑟夫病(MJD)是一种常染色体显性遗传性共济失调,最初在亚速尔群岛和葡萄牙裔人群中被发现。随后,在日本、巴西、澳大利亚和中国也发现了这种疾病。平均发病年龄为35至40岁。核心症状包括进行性共济失调、构音障碍、姿势不稳、眼球震颤、眼睑退缩和面部肌束震颤。肌张力障碍在年轻患者中通常较为突出。三种不同的表型似乎反映了单一突变基因的临床谱。神经病理学涉及传入和传出小脑系统,小脑皮质和下橄榄核保留。脊髓小脑通路、黑质和脑神经运动核也受累。该疾病是由于14号染色体q32.1区域的CAG重复序列不稳定所致。在法裔和德裔家族中发现的一种常染色体显性遗传性共济失调(SCA - 3)也与14号染色体的这一区段有关。本文讨论了MJD与其他显性遗传性共济失调之间的关系。

相似文献

1
Machado-Joseph disease.马查多-约瑟夫病
Clin Neurosci. 1995;3(1):17-22.
2
Molecular and clinical correlations in spinocerebellar ataxia type 3 and Machado-Joseph disease.3型脊髓小脑共济失调与马查多-约瑟夫病的分子与临床关联
Ann Neurol. 1995 Jul;38(1):68-72. doi: 10.1002/ana.410380113.
3
Muscle excitability abnormalities in Machado-Joseph disease.马查多-约瑟夫病中的肌肉兴奋性异常。
Arch Neurol. 2008 Apr;65(4):525-9. doi: 10.1001/archneur.65.4.525.
4
Spinocerebellar ataxia 3 and Machado-Joseph disease: clinical, molecular, and neuropathological features.脊髓小脑共济失调3型与马查多-约瑟夫病:临床、分子及神经病理学特征
Ann Neurol. 1996 Apr;39(4):490-9. doi: 10.1002/ana.410390411.
5
Somatic mosaicism in the central nervous system in spinocerebellar ataxia type 1 and Machado-Joseph disease.脊髓小脑共济失调1型和马查多-约瑟夫病中枢神经系统中的体细胞镶嵌现象。
Ann Neurol. 1996 Aug;40(2):199-206. doi: 10.1002/ana.410400211.
6
[Some problems on the clinical phenotype of Machado-Joseph disease in relation between their ages at onset].[马查多-约瑟夫病临床表型与发病年龄关系的若干问题]
No To Shinkei. 1993 Mar;45(3):246-54.
7
Dominantly inherited ataxias: lessons learned from Machado-Joseph disease/spinocerebellar ataxia type 3.显性遗传性共济失调:从马查多-约瑟夫病/脊髓小脑共济失调3型中汲取的经验教训。
Semin Neurol. 2007 Apr;27(2):133-42. doi: 10.1055/s-2007-971172.
8
The relationship between trinucleotide repeat length and phenotypic variation in Machado-Joseph disease.马查多-约瑟夫病中三核苷酸重复序列长度与表型变异的关系。
J Neurol Sci. 1996 Jul;139(1):52-7.
9
Brain regional differences in the expansion of a CAG repeat in the spinocerebellar ataxias: dentatorubral-pallidoluysian atrophy, Machado-Joseph disease, and spinocerebellar ataxia type 1.脊髓小脑共济失调中CAG重复序列扩增的脑区差异:齿状红核苍白球路易体萎缩症、马查多-约瑟夫病和脊髓小脑共济失调1型
Ann Neurol. 1997 Apr;41(4):505-11. doi: 10.1002/ana.410410414.
10
Somatic mosaicism of the CAG repeat expansion in spinocerebellar ataxia type 3/Machado-Joseph disease.脊髓小脑共济失调3型/马查多-约瑟夫病中CAG重复序列扩增的体细胞镶嵌现象。
Hum Mutat. 1998;11(1):23-7. doi: 10.1002/(SICI)1098-1004(1998)11:1<23::AID-HUMU4>3.0.CO;2-M.

引用本文的文献

1
A survey of protein interactions and posttranslational modifications that influence the polyglutamine diseases.一项关于影响多聚谷氨酰胺疾病的蛋白质相互作用和翻译后修饰的调查。
Front Mol Neurosci. 2022 Sep 14;15:974167. doi: 10.3389/fnmol.2022.974167. eCollection 2022.
2
Chaperone-assisted E3 ligase CHIP: A double agent in cancer.伴侣蛋白辅助的E3连接酶CHIP:癌症中的双面角色。
Genes Dis. 2021 Sep 1;9(6):1521-1555. doi: 10.1016/j.gendis.2021.08.003. eCollection 2022 Nov.
3
Cerebellar morphometric and spectroscopic biomarkers for Machado-Joseph Disease.
Machado-Joseph病的小脑形态学和光谱生物标志物
Acta Neuropathol Commun. 2022 Mar 19;10(1):37. doi: 10.1186/s40478-022-01329-4.
4
Polyglutamine Ataxias: Our Current Molecular Understanding and What the Future Holds for Antisense Therapies.多聚谷氨酰胺共济失调症:我们当前的分子理解以及反义疗法的未来展望
Biomedicines. 2021 Oct 20;9(11):1499. doi: 10.3390/biomedicines9111499.
5
ULK overexpression mitigates motor deficits and neuropathology in mouse models of Machado-Joseph disease.ULK 过表达减轻了 Machado-Joseph 病小鼠模型的运动缺陷和神经病理学。
Mol Ther. 2022 Jan 5;30(1):370-387. doi: 10.1016/j.ymthe.2021.07.012. Epub 2021 Jul 21.
6
Development of an AAV-Based MicroRNA Gene Therapy to Treat Machado-Joseph Disease.开发基于腺相关病毒的微小RNA基因疗法治疗马查多-约瑟夫病。
Mol Ther Methods Clin Dev. 2019 Oct 28;15:343-358. doi: 10.1016/j.omtm.2019.10.008. eCollection 2019 Dec 13.
7
From Pathogenesis to Novel Therapeutics for Spinocerebellar Ataxia Type 3: Evading Potholes on the Way to Translation.从发病机制到脊髓小脑共济失调 3 型的新型治疗方法:在转化之路上避开陷阱。
Neurotherapeutics. 2019 Oct;16(4):1009-1031. doi: 10.1007/s13311-019-00798-1.
8
Repeated Mesenchymal Stromal Cell Treatment Sustainably Alleviates Machado-Joseph Disease.重复间充质基质细胞治疗可持续缓解 Machado-Joseph 病。
Mol Ther. 2018 Sep 5;26(9):2131-2151. doi: 10.1016/j.ymthe.2018.07.007. Epub 2018 Jul 12.
9
Cognitive Changes in the Spinocerebellar Ataxias Due to Expanded Polyglutamine Tracts: A Survey of the Literature.由多聚谷氨酰胺序列扩增导致的脊髓小脑共济失调的认知变化:文献综述
Brain Sci. 2017 Jul 14;7(7):83. doi: 10.3390/brainsci7070083.
10
Unravelling Endogenous MicroRNA System Dysfunction as a New Pathophysiological Mechanism in Machado-Joseph Disease.揭示内源性微小RNA系统功能障碍作为马查多-约瑟夫病新的病理生理机制
Mol Ther. 2017 Apr 5;25(4):1038-1055. doi: 10.1016/j.ymthe.2017.01.021. Epub 2017 Feb 22.